Study of an injected treatment for bladder control after spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests a new medication injected directly into the bladder muscle to help reduce urine leakage in people with spinal cord injuries. It is for those who have tried other treatments without enough success and are considering more invasive options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your spinal cord injury is in the upper or middle back area (above the sacral level) and happened at least 1 year ago, but no more than 12 years ago.
- Your spinal cord injury is 'stable', meaning it hasn't gotten worse recently.
- You have had urine leakage caused by bladder overactivity for at least 3 months.
- You have tried bladder medications for at least 3 months but still leak urine at least 8 times a week, or you had bad side effects from them.
- If you've tried Botox for the bladder, your last treatment was at least 6 months ago, and you still leak urine at least 8 times a week.
- You are able to use a catheter to empty your bladder (clean intermittent catheterization).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving Botox injections early (within 20 weeks of injury) into the bladder muscle can help with bladder function and prevent problems. It may help people with recent, severe spinal cord injuries above the T6 level.
This trial tests a non-invasive nerve stimulation treatment (TTNS) to help people with spinal cord injury who have bladder overactivity. It may reduce urgent urination and improve bladder control.
This study tests a spinal cord stimulator to help improve bladder and pelvic function in people with a spinal cord injury. You would use a small device placed near the spine that sends electrical pulses to help control your bladder better.
This trial tests a treatment that combines magnetic stimulation and ultrasound to help people with spinal cord injuries who have overactive bladder muscles (detrusor overactivity). It may reduce urinary urgency and leakage.
This study tests how well and how safely vibegron works long-term in children (ages 2 to under 18) with a nerve-related bladder condition, who regularly use intermittent catheterization. It also tracks how the body processes the medicine and whether it helps bladder control over time.
This trial tests a nerve-stimulation approach to improve bladder control in people with spinal cord injury. It specifically targets bladder problems that require clean intermittent catheter use and includes regular testing over 6 months.
Hear when a new Neurogenic Detrusor Overactivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.